Blood high mobility group box 1 levels are not a suitable biomarker for disease activity or severity in nonsegmental vitiligo
Clin Exp Dermatol
.
2021 Dec;46(8):1597-1599.
doi: 10.1111/ced.14782.
Epub 2021 Jul 17.
Authors
S Park
1
,
E J Lee
1
,
J Y Kim
1
,
Y J Bae
1
,
S H Oh
1
Affiliation
1
Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
PMID:
34080225
DOI:
10.1111/ced.14782
No abstract available
Publication types
Letter
MeSH terms
Adult
Biomarkers / blood*
Female
HMGB1 Protein / blood*
Humans
Male
Middle Aged
Severity of Illness Index*
Vitiligo / blood*
Vitiligo / classification
Substances
Biomarkers
HMGB1 Protein
HMGB1 protein, human
Grants and funding
HI18C0262/Korea Health Industry Development Institute/Republic of Korea